The Ability of Prostate Health Index (PHI) to Predict Gleason Score in Patients With Prostate Cancer and Discriminate Patients Between Gleason Score 6 and Gleason Score Higher Than 6—A Study on 320 Patients After Radical Prostatectomy-Reference-Cited by-同舟云学术

The Ability of Prostate Health Index (PHI) to Predict Gleason Score in Patients With Prostate Cancer and Discriminate Patients Between Gleason Score 6 and Gleason Score Higher Than 6—A Study on 320 Patients After Radical Prostatectomy

Published:2018-01 Issue: Volume:17 Page:153303381878737
ISSN:1533-0346
Container-title:Technology in Cancer Research & Treatment
language:en
Short-container-title:Technol Cancer Res Treat

Author:

Dolejsova Olga¹,Kucera Radek²^ORCID,Fuchsova Radka²,Topolcan Ondrej²,Svobodova Hana¹,Hes Ondrej³,Eret Viktor¹,Pecen Ladislav²,Hora Milan¹

Affiliation:

1. Department of Urology, University Hospital and Faculty of Medicine in Pilsen, Pilsen, Czech Republic

2. Department of Immunochemistry, University Hospital and Faculty of Medicine in Pilsen, Pilsen, Czech Republic

3. Department of Pathology, University Hospital and Faculty of Medicine in Pilsen, Pilsen, Czech Republic

Publisher

SAGE Publications

Subject

Cancer Research,Oncology

Link

http://journals.sagepub.com/doi/pdf/10.1177/1533033818787377

Reference23 articles.

1. Follow-up of Prostatectomy versus Observation for Early Prostate Cancer

2. The prostate health index PHI predicts oncological outcome and biochemical recurrence after radical prostatectomy - analysis in 437 patients

3. A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preanalytical stability of molecular forms of prostate‐specific antigen in serum samples (PSA, free PSA, [−2]proPSA) and their impact on fPSA/tPSA ratio and PHI;The Prostate;2024-02-27

2. Prostate health index (PHI) as an accurate prostate cancer predictor;Journal of Cancer Research and Clinical Oncology;2023-05-19

3. Multimodal convolutional neural networks based on the Raman spectra of serum and clinical features for the early diagnosis of prostate cancer;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2023-05

4. Relationship between Proclarix and the Aggressiveness of Prostate Cancer;Molecular Diagnosis & Therapy;2023-04-20

5. Serum multi-cytokines screening identifies TRAIL and IL-10 as probable new biomarkers for prostate health index diagnostic utility adjustment in grey zone aggressive prostate cancer detection: A single-center data in China;Frontiers in Immunology;2022-08-18